0001415889-15-003713.txt : 20151113 0001415889-15-003713.hdr.sgml : 20151113 20151113174542 ACCESSION NUMBER: 0001415889-15-003713 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20151111 FILED AS OF DATE: 20151113 DATE AS OF CHANGE: 20151113 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ACADIA PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001070494 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 061376651 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3611 VALLEY CENTRE DRIVE STREET 2: SUITE 300 CITY: SAN DIEGO STATE: CA ZIP: 92130 BUSINESS PHONE: 858-558-2871 MAIL ADDRESS: STREET 1: 3611 VALLEY CENTRE DRIVE STREET 2: SUITE 300 CITY: SAN DIEGO STATE: CA ZIP: 92130 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Iversen Leslie L CENTRAL INDEX KEY: 0001291623 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-50768 FILM NUMBER: 151230453 MAIL ADDRESS: STREET 1: C/O UNIVERSITY OF OXFORD STREET 2: MANSFIELD ROAD CITY: OXFORD STATE: X0 ZIP: OX1 3QT 4 1 form4-11132015_021134.xml X0306 4 2015-11-11 0001070494 ACADIA PHARMACEUTICALS INC ACAD 0001291623 Iversen Leslie L 3611 VALLEY CENTRE DRIVE, SUITE 300 SAN DIEGO CA 92130 true false false false Common Stock 2015-11-11 4 M 0 6000 9.04 A 42127 D Common Stock 2015-11-11 4 M 0 10000 9.04 A 52127 D Common Stock 2015-11-11 4 M 0 9126 9.04 A 61253 D Common Stock 2015-11-11 4 M 0 4874 1.75 A 66127 D Common Stock 2015-11-11 4 S 0 30000 36.0109 D 36127 D Stock option (right to buy) 9.04 2015-11-11 4 M 0 6000 0 D 2016-06-12 Common Stock 6000 0 D Stock option (right to buy) 9.04 2015-11-11 4 M 0 10000 0 D 2016-06-12 Common Stock 10000 0 D Stock option (right to buy) 9.04 2015-11-11 4 M 0 9126 0 D 2016-06-12 Common Stock 9126 0 D Stock option (right to buy) 1.75 2015-11-11 4 M 0 4874 0 D 2021-06-09 Common Stock 4874 33697 D The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in September 2015. The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $35.67 to $36.44 per share, inclusive. The reporting person undertakes to provide ACADIA Pharmaceuticals Inc., any security holder of ACADIA Pharmaceuticals Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the foregoing range. 25% of the shares subject to the Stock Option vested and became exercisable at the end of each 3-month period following the grant date of June 13, 2006. 25% of the shares subject to the Stock Option vested and became exercisable at the end of each 3-month period following the grant date of June 10, 2011. /s/ Glenn F. Baity, Attorney-in-Fact 2015-11-13